A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective

• Үндсэн зохиолчид: Marcus Heise (Зохиогч), Petra Staubach (Зохиогч), Georgios Nikolakis (Зохиогч), Lukas Schollenberger (Зохиогч), Melanie Mauch (Зохиогч), Marion Burckhardt (Зохиогч), Marina Zamsheva (Зохиогч), Alexandra Strobel (Зохиогч), Gero Langer (Зохиогч), Falk Bechara (Зохиогч), Uwe Kirschner (Зохиогч), Katharina Hennig (Зохиогч), Christian Kunte (Зохиогч), Matthias Goebeler (Зохиогч), Maurizio Podda (Зохиогч), Stephan Grabbe (Зохиогч), Michael Schultheis (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

AbstractBackground Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting approximately 1% of the population. The patient journey through the German health care system leads to high disease burden and substantial treatment costs. The EsmAiL study showed that an innovative, in...